Skip to main content

SDZ R30 Pill - yellow capsule/oblong

Pill with imprint SDZ R30 is Yellow, Capsule/Oblong and has been identified as Methylphenidate Hydrochloride Extended-Release 30 mg. It is supplied by Sandoz Inc.

Methylphenidate is used in the treatment of ADHD; Narcolepsy; Depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for SDZ R30

Methylphenidate Hydrochloride Extended-Release

Imprint
SDZ R30
Strength
30 mg
Color
Yellow
Shape
Capsule/Oblong (capsule)
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Sandoz Inc.
National Drug Code (NDC)
00781-2385

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.